🇺🇸 FDA
Pipeline program

Lifileucel plus Pembrolizumab

IOV-MEL-301

Phase 3 mab active

Quick answer

Lifileucel plus Pembrolizumab for Metastatic Melanoma is a Phase 3 program (mab) at IOVANCE BIOTHERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
IOVANCE BIOTHERAPEUTICS, INC.
Indication
Metastatic Melanoma
Phase
Phase 3
Modality
mab
Status
active

Clinical trials